Exciting News at ISP HEALTHCARE GmbH! We are delighted to share that our team is growing. This year, we have welcomed two talented new members who are already making a significant impact. Let's extend a warm welcome to Vanessa Luzak and Thomas Seefeld. With their expertise in biochemistry and finance, they bring invaluable knowledge and skills to our team. We are thrilled to have you with us and look forward to achieving great success together! Welcome aboard! #newjoiner #privateequity #healthcare
ISP HEALTHCARE GmbH
Unternehmensberatung
Consulting boutique focused on investor advice, value creation & commercial due diligence in healthcare & life sciences
Info
ISP HEALTHCARE GmbH (ISP) is a life science & healthcare consulting firm focused on strategy advice for investors targeting the tech and healthcare space and for management of companies in these fields. ISP's clients range from local and international financial investors with mid & large cap focus to management of SMEs. ISP specializes in analyzing and fostering companies' commercial attractiveness in the context of company acquisition and beyond. Target companies typically belong to the life science industry (e.g., biotech, CDMOs), medtech (e.g., manufacturer of implants) or the healthcare software space (e.g., telemedicine providers). Most target companies are in the DACH region. ISP Managing Director: Achim Seyr
- Website
-
https://www.isp-healthcare.com/
Externer Link zu ISP HEALTHCARE GmbH
- Branche
- Unternehmensberatung
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- München
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- Value Creation, Commercial Due Diligence, Healthcare, Investor Advice und Life Sciences
Orte
-
Primär
Wegbeschreibung
Herrnstr. 44
München, 80539, DE
Beschäftigte von ISP HEALTHCARE GmbH
Updates
-
Congratulations to GREENPEAK Partners and ACADEMIA Gruppe to their successful close of GREEBPEAK Continuation Fund I ISP HEALTHCARE GmbH provided Commercial VDD services to ACADEMIA Gruppe
We are happy to announce the successful close of GREENPEAK Continuation Fund I with total commitments of ca. EUR 350 million. GREENPEAK is delighted to have secured backing from a top-tier group of investors. Continuation Fund I will enable both of our portfolio companies ACADEMIA Gruppe and CERTANIA to continue their successful investment strategy over the coming years. For more information please read here: https://lnkd.in/dAPQ-gdN Thank you to our advisors: PJT Partners (Financial Advisory), ISP HEALTHCARE GmbH (Commercial DD), Roedl & Partner (Financial/Tax), and Stephenson Harwood LLP, FMDH Fischer Mues Dittmer Rechtsanwälte PartG mbB Rechtsanwälte, McDermott Will & Emery Deutschland, and Orbit | Fund Boutique (Legal). Dr. Julia Keim, LL.M.; Daniel Beringer Florian Kopp Philipp Meyer Jens Cremer Stefan Melzer Antje Bräunling Germana Veneziano Niemeier, CFA Simon Schachinger Stephan Rau Gabor Mues Gabriel Boghossian Sarah de Ste Croix Mimoun Houbbani Yana Matova Achim Seyr Paula Salvà de Torres Debra Kelsall Yassin Knocke Elena Laleh #PrivateEquity #ContinuationFund #AllAboutFunds
-
New faces at ISP HEALTHCARE GmbH! We're thrilled to announce that ISP continues to grow. This year, three new joiners started and are a great addition to our team. Please join us in giving a warm welcome to Konstantin Stölting, Joshua Hesse and Moritz Bensel. With our new colleagues we not just expand our team but also enrich our expertise in finance, biochemistry, and medicine! We wish you much success and are happy to have you on board. Together, we will continue to achieve great things! #privateequity #healthcare #newjoiner
-
-
Thrilled to share highlights from an incredible ski event with ISP HEALTHCARE GmbH at #Zürs this year. Blessed with perfect skiing conditions in #Arlberg, our team not only enjoyed the exhilarating downhill runs but also engaged in meaningful conversations and exchanged ideas beyond the office. Kicking off the new year with such a dynamic start has left us all highly motivated. We are now even more eager to dive into our upcoming projects and are looking forward to new exciting opportunities in the #healthcare & #lifesciences sector. Here's to a year of growth, collaboration, and breakthroughs! #privateequity #medtech #skievent
-
-
Congrats to EMZ Partners and FotoFinder Systems GmbH to their strategic partnership with DermLite - creating a global dermatology device powerhouse! ISP HEALTHCARE GmbH acted as a commercial advisor to FotoFinder Systems GmbH and EMZ Partners
EMZ Partners supports the management teams of FotoFinder Systems GmbH and DermLite in building a leading player in dermoscopy! 🚀🚀 Congratulations to the EMZ deal team: Klaus Maurer, Annabell Grimm and Luis Bischof! 👏👏 Many thanks to our advisors: Venable LLP, LUPP PARTNER, taxess, ISP HEALTHCARE GmbH, RSM Ebner Stolz, Houlihan Lokey and Goodwin. https://lnkd.in/eVQdeX-m
EMZ Partners supports the management teams of Fotofinder systems and Dermlite in building a leading player in dermoscopy - Emz Partners
https://emzpartners.com
-
We are excited to welcome Benjamin Faist as a senior consultant in our team! Before joining ISP, Benjamin has worked at Eurofins focusing on international business development and at bioMérieux where he set up medical affairs in Europe. Prior to that Benjamin was a consultant at BCG serving clients in the healthcare sector on strategy and investment topics. Benjamin studied medicine at Universitätsklinikum Hamburg Eppendorf, conducted his doctoral thesis at Bernhard Nocht Institute for Tropical Medicine and has worked as a medical doctor at TUM´s Klinikum rechts der Isar where he received his board certification for medical microbiology. In his free time Benjamin enjoys Tennis and Skiing and is passionate about fashion, food and dancing to Urban Latin Music with his son. Welcome to the ISP family, Benjamin
-
-
We are excited to introduce our new colleague Florian Timm! Florian is joining us as Associate. Prior to ISP, Florian interned at Stern Stewart & Company focusing on strategy consulting and private equity. Additionally, he gained experience in Life Science consulting at Simon-Kucher and WMC Healthcare. Florian studied general management (BSc.) at the EBS Universität für Wirtschaft und Recht and holds a Master in Management (MSc.) from the Esade Business School. In his free time, he enjoys sailing, tennis, and skiing. Welcome to the ISP family, Florian!
-
-
Congrats to Maxburg Capital Partners for their strategic partnership with MLASE AG - looking forward to seeing MLases next phase of growth! ISP HEALTHCARE GmbH acted as a commercial advisor to Maxburg Capital Partners
Maxburg is proud to announce our partnership with MLase AG, a market-leading CDMO specializing in UV-light medical products, based in Germering, near Munich. The team led by the managers Markus Enders, Johannes Junger and Thomas Dickenhorst, is dedicated to incorporating the latest medical, physical, optical, and electrotechnical advancements into their premium products. These products form an integral part of numerous OEM systems used in applications such as refractive eye surgery, angiology, and glaucoma treatment. Since its establishment in 2007, MLase has excelled in the development and manufacturing of innovative, high-quality laser and light systems. Working closely with a notable roster of medical blue-chip OEM customers, MLase has consistently delivered innovative solutions. In partnership with MLase's management, our aim is to foster the continuous growth of the company. We plan to expand the product portfolio while building upon MLase's strong reputation as a med-tech CDMO committed to highest quality and service excellence. We extend our gratitude to our esteemed partners who played pivotal roles in facilitating this process, including Pictet (Jan Henrik Reichenbach, Christian Eckert), EHW (Dr. Jan-Henning Wyen, Dr. Alexander Ego, Dr. Achim Spengler), ISP (Achim Seyr, Dr. Carina Gradl), KPMG (Claus Buhmann, Roman Meissner, Thomas Weber, U. Tobias Ackert), KPNZ (Dr. Kai-Uwe Plath, Matthias Alexander Struck, Dr. Enno ter Hazeborg), Kaltwasser (Dr. Jan-Tobias Häser), PWWL (Dr. Marius Fritzsche), Pöllath Partner (Gerald Herrmann, Jannis Lührs), Clifford Chance (Steffen Schellschmidt, Peter Gierl), and CMS (Kai Neuhaus). We also expressly thank the advisors to the sell-side Houlihan Lokey (Daniel T. Fritz, Bastian Sprenger, Willi Schmid, CFA), LUPP PARTNER (Stefan Jörgens, Thomas Krawitz, Anna-Lena Haggeney, LL.M., Konrad Seibold), Alvarez & Marsal (Jürgen Zapf, Marcus Ölander), LEK (Tobias Kösters, Dr. Stefan Schrettle, Lena C. Thamm, Konstanze Inderhees), Kleeberg & Partner (Jürgen Schmidt) and Dieter Gauglitz for their professionalism and collaboration during the transaction process. MLase marks the third investment within our latest fund, Maxburg Beteiligungen IV, launched in the summer of 2022. This collaboration stands as a significant milestone, and we look forward to a future of mutual growth and success.
-